Seegene, Inc. (096530.KQ)
KRW 23550.0
(-1.26%)
KRW 23550.0
(-1.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1251.45 Billion KRW | -10.02% |
| 2022 | 1390.77 Billion KRW | -6.64% |
| 2021 | 1489.71 Billion KRW | 36.1% |
| 2020 | 1094.57 Billion KRW | 459.27% |
| 2019 | 195.71 Billion KRW | 18.17% |
| 2018 | 165.61 Billion KRW | 4.78% |
| 2017 | 158.05 Billion KRW | -24.72% |
| 2016 | 209.97 Billion KRW | 6.78% |
| 2015 | 196.62 Billion KRW | 42.02% |
| 2014 | 138.45 Billion KRW | 7.3% |
| 2013 | 129.03 Billion KRW | 54.32% |
| 2012 | 83.61 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1267.64 Billion KRW | 1.32% |
| 2024 Q1 | 1251.14 Billion KRW | -0.02% |
| 2023 Q2 | 1276.02 Billion KRW | -4.44% |
| 2023 Q4 | 1251.45 Billion KRW | -0.43% |
| 2023 FY | 1251.45 Billion KRW | -10.02% |
| 2023 Q1 | 1335.27 Billion KRW | -3.99% |
| 2023 Q3 | 1256.87 Billion KRW | -1.5% |
| 2022 Q4 | 1390.77 Billion KRW | -2.86% |
| 2022 Q3 | 1431.79 Billion KRW | -4.86% |
| 2022 Q2 | 1504.94 Billion KRW | -10.47% |
| 2022 Q1 | 1680.88 Billion KRW | 12.83% |
| 2022 FY | 1390.77 Billion KRW | -6.64% |
| 2021 Q1 | 1228.99 Billion KRW | 12.28% |
| 2021 Q4 | 1489.71 Billion KRW | 17.5% |
| 2021 Q3 | 1267.87 Billion KRW | 3.32% |
| 2021 FY | 1489.71 Billion KRW | 36.1% |
| 2021 Q2 | 1227.14 Billion KRW | -0.15% |
| 2020 Q3 | 800.18 Billion KRW | 60.0% |
| 2020 FY | 1094.57 Billion KRW | 459.27% |
| 2020 Q1 | 265.31 Billion KRW | 35.56% |
| 2020 Q2 | 500.11 Billion KRW | 88.5% |
| 2020 Q4 | 1094.57 Billion KRW | 36.79% |
| 2019 Q1 | 163.6 Billion KRW | -0.12% |
| 2019 FY | 195.71 Billion KRW | 18.17% |
| 2019 Q3 | 182.59 Billion KRW | -0.02% |
| 2019 Q2 | 182.63 Billion KRW | 11.63% |
| 2019 Q4 | 195.71 Billion KRW | 7.19% |
| 2018 Q3 | 162.3 Billion KRW | -9.65% |
| 2018 Q2 | 179.63 Billion KRW | 3.76% |
| 2018 Q1 | 173.12 Billion KRW | 10.44% |
| 2018 FY | 165.61 Billion KRW | 4.78% |
| 2018 Q4 | 163.8 Billion KRW | 0.92% |
| 2017 Q4 | 156.75 Billion KRW | -15.7% |
| 2017 Q2 | 213.56 Billion KRW | 2.23% |
| 2017 FY | 158.05 Billion KRW | -24.72% |
| 2017 Q1 | 208.91 Billion KRW | 0.62% |
| 2017 Q3 | 185.94 Billion KRW | -12.93% |
| 2016 FY | 209.97 Billion KRW | 6.78% |
| 2016 Q3 | 199.07 Billion KRW | -0.6% |
| 2016 Q1 | 196.16 Billion KRW | 1.09% |
| 2016 Q2 | 200.28 Billion KRW | 2.1% |
| 2016 Q4 | 207.61 Billion KRW | 4.29% |
| 2015 Q2 | 148.38 Billion KRW | 2.29% |
| 2015 FY | 196.62 Billion KRW | 42.02% |
| 2015 Q4 | 194.04 Billion KRW | 0.41% |
| 2015 Q3 | 193.25 Billion KRW | 30.24% |
| 2015 Q1 | 145.06 Billion KRW | 4.77% |
| 2014 Q4 | 138.45 Billion KRW | -0.32% |
| 2014 Q3 | 138.89 Billion KRW | 1.85% |
| 2014 Q2 | 136.36 Billion KRW | 4.5% |
| 2014 Q1 | 130.49 Billion KRW | 1.13% |
| 2014 FY | 138.45 Billion KRW | 7.3% |
| 2013 FY | 129.03 Billion KRW | 54.32% |
| 2013 Q3 | 94.81 Billion KRW | 2.48% |
| 2013 Q4 | 129.03 Billion KRW | 36.1% |
| 2013 Q1 | 88.83 Billion KRW | 6.25% |
| 2013 Q2 | 92.52 Billion KRW | 4.15% |
| 2012 FY | 83.61 Billion KRW | 0.0% |
| 2012 Q4 | 83.61 Billion KRW | 4.75% |
| 2012 Q3 | 79.82 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 320.54 Billion KRW | -290.412% |
| InBody Co.,Ltd | 274.45 Billion KRW | -355.975% |
| Curexo Inc. | 107.36 Billion KRW | -1065.555% |
| i-SENS, Inc. | 498.81 Billion KRW | -150.884% |
| Ray Co., Ltd. | 259.55 Billion KRW | -382.158% |
| Gencurix Inc. | 33.5 Billion KRW | -3635.464% |
| Sugentech Inc. | 133.18 Billion KRW | -839.62% |
| L&C Bio Co., Ltd | 262.23 Billion KRW | -377.234% |